Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05143554 · ClinicalTrials.gov registry record · NA
Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting
A NA study, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05143554 is a NA study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 18 participants.
The verdict
NCT05143554, a NA study, was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of auricular percutaneous electrical nerve field stimulator in children, adolescents and young adults with chemotherapy induced nausea and vomiting.
Interventions
- DEVICE Auricular percutaneous neurostimulation
- DEVICE Sham percutaneous neurostimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2025-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05143554
The ClinicalTrials.gov registry entry for NCT05143554 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Auricular percutaneous neurostimulation is the first listed.
NCT05143554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05143554 about?
NCT05143554 is a clinical study titled "Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting". This study evaluates the efficacy of auricular percutaneous electrical nerve field stimulator in children, adolescents and young adults with chemotherapy induced nausea and vomiting.
What is the current status of trial NCT05143554?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2021-04-29. Estimated completion is 2025-09-23.
What interventions are being tested in trial NCT05143554?
The interventions under investigation include: Auricular percutaneous neurostimulation (DEVICE), Sham percutaneous neurostimulation (DEVICE).
Who is sponsoring clinical trial NCT05143554?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.